American Innovation, Impacting the World
With $32 billion committed from 2025 through 2030, Gilead is building
the future of medicine — right here in the United States.
Breakthroughs Born in
America, Delivered Worldwide
From our headquarters in Foster City, California, we pursue world-class science to tackle some of the greatest public health challenges. With deep roots in American innovation, we are building more than medicine — we’re building opportunity, health and hope.
Through $32 billion in planned U.S. investments, we’re strengthening our domestic footprint to power the next era of discovery, job creation and public health preparedness — while continuing to invest globally to ensure patients everywhere benefit from our science.
Investing in Our
Promise
U.S. capital and operational investment through 2030
Of R&D capital infrastructure anchored in the U.S.
Direct jobs created through 2030, plus 2,200 supported roles
A Stronger Workforce. A Healthier Future.
Since 2017, Gilead has added more than 16,000 high-quality U.S. jobs. Our latest investments will
generate an estimated $43 billion in domestic economic impact by 2030 — delivering long-term
benefits for patients, employees and the communities we call home.
$43B projected U.S. economic impact through 2030
70%+ of U.S. employees
are dedicated to R&D
16,000+ U.S. jobs added
since 2017
Engineering a New Era of Innovation
Bay Area Born. Science Powered & AI Fueled. Future Ready.
Innovation is at the heart of all we do. That’s why we’re continually advancing how we discover, develop and deliver the next generation of medicines across our therapeutic areas of virology, oncology and inflammation.
From collaborating with biotech startups across the U.S. to integrating AI into our biopharma campuses, our investments are shaping a new standard in American science and infrastructure.
Our Model for the Future
Homegrown Science. Uplifting U.S. Communities.
More than 80% of Gilead’s global profits are reinvested in the U.S. — supporting scientific advances, workforce development and healthier communities. With most of our intellectual property based in America and operations anchored in U.S. communities, we are ensuring that tomorrow’s life-changing therapies are discovered, developed and delivered close to home.